Publication

Pou5f1b inhibitors

Didier Trono, Françoise Gisou van der Goot Grunberg, Laurence Gouzi Abrami, Sandra Eloise Kjeldsen, Laia Simo Riudalbas
2024

Abstract

The invention provides an agent modulating the expression and/or activity of i) the POU5F1B protein, a fragment or variant thereof, ii) an mRNA encoding POU5F1B, a fragment or variant thereof and/or iii) the POU5F1B gene. Preferably, the agent is for use in the treatment and/or prevention of a disease linked to the expression of POU5F1B in a subject in need thereof.

Official source

https://infoscience.epfl.ch/entities/publication/46667de3-3615-4de5-84b2-f18c17b7d14f

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.